Literature DB >> 17721398

Rethinking approaches to risk reduction for injection drug users: differences in drug type affect risk for HIV and hepatitis C virus infection through drug-injecting networks.

Prithwish De1, Joseph Cox, Jean-François Boivin, Robert W Platt, Ann M Jolly.   

Abstract

OBJECTIVE: To identify and compare the drug-injecting network characteristics of cocaine and heroin injectors associated with a risk of HIV and hepatitis C virus (HCV).
METHODS: Active injectors were recruited from syringe exchange and methadone programs. Characteristics of all participants and their social networks were elicited. Regression analysis using generalized estimating equations examined the network characteristics of injection drug users (IDUs) relative to cocaine or heroin use in the past 6 months.
RESULTS: Of 282 IDUs, 228 (81%) used cocaine and 54 (19%) used heroin as their primary injected drug. In analyses adjusted for age and gender, cocaine injectors compared with heroin injectors were more likely to live in unstable housing (odds ratio [OR] = 3.55, 95% confidence interval [CI]: 1.49 to 8.40), self-report HCV infection (OR = 4.69, 95% CI: 2.14 to 10.31), and have a greater number of IDUs in their social network (OR = 1.61, 95% CI: 1.14 to 2.28) and were less likely to be polydrug users (OR = 0.06, 95% CI: 0.02 to 0.16) and to have social support (OR = 0.97, 95% CI: 0.95 to 0.99). The injecting networks of cocaine users were more likely to have members who were older (OR = 1.08, 95% CI: 1.04 to 1.12), had a history of shooting gallery use (OR = 2.27, 95% CI: 1.08 to 4.76), and had shorter relationships with the subject (OR = 0.91, 95% CI: 0.85 to 0.97).
CONCLUSIONS: Beyond personal behaviors, HIV and HCV infection risk seems to be linked to social network traits that are determined by drug type. Prevention efforts to control the spread of bloodborne viruses among IDUs could benefit from tailoring interventions according to the type of drug used.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17721398     DOI: 10.1097/QAI.0b013e3181565dde

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  7 in total

1.  THE FIRST INJECTION EVENT: DIFFERENCES AMONG HEROIN, METHAMPHETAMINE, COCAINE, AND KETAMINE INITIATES.

Authors:  Stephen E Lankenau; Karla D Wagner; Jennifer Jackson Bloom; Bill Sanders; Dodi Hathazi; Charles Shin
Journal:  J Drug Issues       Date:  2010

2.  Injection risk behaviors among rural drug users: implications for HIV prevention.

Authors:  Jennifer R Havens; Carrie B Oser; Carl G Leukefeld
Journal:  AIDS Care       Date:  2011-05

3.  Continuing HIV risk in New York City injection drug users: the association of syringe source and syringe sharing.

Authors:  Samuel M Jenness; Holly Hagan; Kai-Lih Liu; Travis Wendel; Christopher S Murrill
Journal:  Subst Use Misuse       Date:  2011       Impact factor: 2.164

4.  Social-level correlates of shooting gallery attendance: a focus on networks and norms.

Authors:  Karin E Tobin; Melissa Davey-Rothwell; Carl A Latkin
Journal:  AIDS Behav       Date:  2010-10

5.  Alcohol and HIV sexual risk behaviors among injection drug users.

Authors:  Kamyar Arasteh; Don C Des Jarlais; Theresa E Perlis
Journal:  Drug Alcohol Depend       Date:  2008-02-01       Impact factor: 4.492

6.  Addressing injecting related risks among people who inject both opioids and stimulants: Findings from an Australian survey of people who inject drugs.

Authors:  L Brener; T Caruana; T Broady; E Cama; N Ezard; A Madden; C Treloar
Journal:  Addict Behav Rep       Date:  2021-12-11

7.  Hepatitis C transmission and treatment in contact networks of people who inject drugs.

Authors:  David A Rolls; Rachel Sacks-Davis; Rebecca Jenkinson; Emma McBryde; Philippa Pattison; Garry Robins; Margaret Hellard
Journal:  PLoS One       Date:  2013-11-01       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.